Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Radiation Planning Assistant (RPA)

K-Number: K222728 · 2023-05-17

ApplicantUniversity of Texas, MD Anderson Cancer Center
Decision Date2023-05-17
Product CodeMUJ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Radiation Planning Assistant (RPA) is a medical device manufactured by University of Texas, MD Anderson Cancer Center. It received FDA 510(k) clearance on 2023-05-17 under approval number K222728. The device is classified under product code MUJ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Radiation Planning Assistant (RPA)?

Radiation Planning Assistant (RPA) is a medical device that received FDA 510(k) clearance on 2023-05-17. It is manufactured by University of Texas, MD Anderson Cancer Center. The 510(k) number is K222728.

When was Radiation Planning Assistant (RPA) approved by the FDA?

Radiation Planning Assistant (RPA) received FDA 510(k) clearance on 2023-05-17, under approval number K222728.

What company makes Radiation Planning Assistant (RPA)?

Radiation Planning Assistant (RPA) is manufactured by University of Texas, MD Anderson Cancer Center.

What is the FDA product code for Radiation Planning Assistant (RPA)?

The FDA product code for Radiation Planning Assistant (RPA) is MUJ.

Related Clinical Trials

NCT06127654 Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy RECRUITING NCT06588543 Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping RECRUITING NCT02761889 Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer COMPLETED NCT04975139 Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks ACTIVE_NOT_RECRUITING NCT07463833 Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology NOT_YET_RECRUITING NCT06988007 Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference NOT_YET_RECRUITING

Related Devices (Code: MUJ)

K162370syngo.via RT Image SuiteSiemens Medical Solutions USA, Inc. K161136Precision Treatment Planning SystemAccuray Incorporated K160093RayStationRaySearch Laboratories AB (PUBL) K151435MRCATPhilips Medical Systems MR Finland K153368Radiance V3Gmv Soluciones Globales Internet S.A.U. K170750RT Elements, Cranial SRS, Spine SRS, Multiple Brain Mets SRS, RT QA, Adaptive Hybrid Surgery Analysis, Dose ReviewBrainlab AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑